News
No increase in risk for major congenital malformations is observed in infants born to mothers receiving smoking cessation therapies, according to a large cohort study.
But semaglutide isn't without side effects. Some users have reported gastrointestinal issues, and a new study suggests that ...
What the study revealed about GLP-1s and their connection to hair loss The study looked at over 3,200 patients, about 60% of ...
Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...
Large retrospective study supports benefits of quitting with smoking cessation medications over risks of smoking.
Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...
Maternal smoking during pregnancy is the leading cause of harm to both mother and baby, contributing to adverse pregnancy ...
Opens in a new tab or window Female semaglutide users had more than a two-fold higher risk for hair loss than users of bupropion-naltrexone. Incidence rates for hair loss were more than double for ...
10mon
Mediafeed on MSNHow to Ask a Doctor for AntidepressantsWhen you’re depressed, seemingly small tasks or activities like brushing your teeth, cooking your favorite carbonara or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results